China Metastatic Liver Cancer Clinical Registry Cohort Database

Sponsor
Anhui Provincial Hospital
Study ID
NCT07602504
Status
Recruiting
Apply to this trial

Conditions

  • Colorectal Cancer Metastatic
  • Liver Cancer
  • Liver Diseases
  • Liver Metastases
  • Metastases to Liver
  • Neoplasms

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Standard of Care for Metastatic Liver Cancer — PROCEDURE
    In this observational patient registry, no specific interventional procedure is assigned by the investigators. Patients included in the database receive standard clinical management and treatments for metastatic liver cancer according to current clinical guidelines and physician's discretion. These procedures may include hepatectomy, ablation, transarterial chemoembolization (TACE), systemic chemotherapy, targeted therapy, or immunotherapy. This registry aims to evaluate the real-world effectiveness and safety of these standard interventions.

Study Details

This study is led by the Department of Hepatobiliary Surgery of the First Affiliated Hospital of the University of Science and Technology of China (USTC), in close collaboration with multiple participating centers nationwide. The primary objective is to establish a standardized, large-scale clinical cohort database specifically for metastatic liver cancer. By collecting comprehensive data on patient demographics, primary tumor characteristics, systemic therapies, and local interventions, this registry aims to elucidate the clinical patterns and prognostic factors of secondary liver malignancies. This database will serve as a robust platform for conducting high-quality real-world studies and advancing evidence-based clinical research in the management of metastatic liver cancer.

Key Dates

First listed
May 22, 2026
Start date
Jun 1, 2026
Status verified
May 2026
Primary completion
May 31, 2031
Completion
May 31, 2036

Study Design

Enrollment
2,000 participants (estimated)

Primary Outcome Measure

Overall Survival [ Time Frame: Up to 10 years ]

Central Contacts

Find similar trials

Nationwide
Liver cancer trialsOncology trialsGI oncology trialsHepatology trials

Related Studies